{"nct_id":"NCT04144517","title":"A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2020-02-05","start_date_type":"ACTUAL","primary_completion_date":"2021-10-08","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MURA"]}